Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
MYO Myomo Inc
- Stocks
- Healthcare
- NYSEAMERICAN: MYO
Price (delayed)
$2.88
Market cap
$103.62M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.14
Enterprise value
$91.72M
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the
Highlights
The company's gross profit has surged by 109% YoY and by 19% QoQ
The revenue has surged by 98% year-on-year and by 19% since the previous quarter
MYO's equity has soared by 99% year-on-year but it is down by 12% since the previous quarter
The quick ratio has contracted by 20% from the previous quarter
The company's debt rose by 2% QoQ
Key stats
What are the main financial stats of MYO
Market
Valuations
Earnings
Shares outstanding
35.98M
Market cap
$103.62M
Enterprise value
$91.72M
Price to earnings (P/E)
N/A
Price to book (P/B)
4.57
Price to sales (P/S)
3.09
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.37
Revenue
$38.63M
Gross profit
$27.5M
Operating income
-$5.84M
Net income
-$5.81M
EBIT
-$5.39M
EBITDA
-$4.26M
Free cash flow
-$4.69M
Per share
Balance sheet
Liquidity
EPS
-$0.14
EPS diluted
-$0.14
Free cash flow per share
-$0.11
Book value per share
$0.63
Revenue per share
$0.93
TBVPS
$0.99
Total assets
$40.87M
Total liabilities
$19.18M
Debt
$8.27M
Equity
$21.69M
Working capital
$19.42M
Debt to equity
0.38
Current ratio
2.66
Quick ratio
2.28
Net debt/EBITDA
2.8
Margins
Efficiency
Dividend
EBITDA margin
-11%
Gross margin
71.2%
Net margin
-15%
Operating margin
-15.1%
Return on assets
-20.1%
Return on equity
-35.6%
Return on invested capital
-54.6%
Return on capital employed
-18.5%
Return on sales
-14%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MYO stock price
How has the Myomo stock price performed over time
Intraday
0%
1 week
-6.19%
1 month
-40.98%
1 year
-15.54%
YTD
-55.28%
QTD
-40.12%
Financial performance
How have Myomo's revenue and profit performed over time
Revenue
$38.63M
Gross profit
$27.5M
Operating income
-$5.84M
Net income
-$5.81M
Gross margin
71.2%
Net margin
-15%
The company's gross profit has surged by 109% YoY and by 19% QoQ
The revenue has surged by 98% year-on-year and by 19% since the previous quarter
The operating margin has soared by 69% YoY and by 21% from the previous quarter
The company's net margin has surged by 69% YoY and by 21% QoQ
Price vs fundamentals
How does MYO's price correlate with its fundamentals
Growth
What is Myomo's growth rate over time
Valuation
What is Myomo stock price valuation
P/E
N/A
P/B
4.57
P/S
3.09
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.37
The EPS rose by 48% YoY and by 13% QoQ
MYO's equity has soared by 99% year-on-year but it is down by 12% since the previous quarter
The price to book (P/B) is 52% less than the last 4 quarters average of 9.5 and 2.8% less than the 5-year quarterly average of 4.7
The revenue has surged by 98% year-on-year and by 19% since the previous quarter
The stock's P/S is 49% below its last 4 quarters average of 6.1 and 19% below its 5-year quarterly average of 3.8
Efficiency
How efficient is Myomo business performance
Myomo's return on invested capital has surged by 74% YoY and by 34% QoQ
The ROS has soared by 70% YoY and by 22% QoQ
The return on assets has surged by 67% year-on-year and by 26% since the previous quarter
MYO's ROE has soared by 62% year-on-year and by 21% since the previous quarter
Dividends
What is MYO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MYO.
Financial health
How did Myomo financials performed over time
Myomo's total assets is 113% higher than its total liabilities
Myomo's total assets has surged by 147% YoY but it has decreased by 3.3% QoQ
The quick ratio has contracted by 20% from the previous quarter
The company's debt is 62% lower than its equity
MYO's equity has soared by 99% year-on-year but it is down by 12% since the previous quarter
The debt to equity has increased by 15% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.